Boehringer Ingelheim International GmbH Reports Findings in Type 2 Diabetes (Analytical validation of Exandra: a clinical decision support system for promoting guideline-directed therapy of type-2 diabetes in primary care - a collaborative...).

A study conducted by Boehringer Ingelheim International GmbH focused on validating a clinical decision support system called Exandra for managing type 2 diabetes (T2D) and its comorbidities. The system was designed to provide treatment recommendations based on clinical practice guidelines from Diabetes Canada. The study found that Exandra displayed a high level of accuracy and precision in providing guideline-directed recommendations for managing T2D and its common comorbidities, indicating its potential as a tool for improving T2D management. The research was published in BMC Medical Informatics and Decision Making and can be accessed online for further information. [Extracted from the article]